Submitted by Anonymous (not verified) on 19 July 2024 - 9:38
Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
Source:
Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals